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1 Introduction 
 
Nanoparticles and nanomedicines are increasingly applied in the manufacture of 
pharmaceuticals and cosmetic products. Nanocarrier-based nanomedicines are comprised of 
polymers, liposomes, dendrimers, quantum dots, nanotubes and their combinations. These 
systems form the basis for the introduction of personalized medicine and are powerful tools 
for the detection of diseases and diagnoses coupled with highly-effective targeted therapy. 
Some major biopolymers are also used in medicine, such as alginic acid, hyaluronic acid, 
chitosan and polyglutamic acid, and nanosystems prepared from these biopolymers. 
Biopolymers are characterized by favourable biological properties, pharmaceutical 
technology and nanotechnological applications. The applied and intended pharmaceutical 
formulations will be described. One of the challenging aims of research at present is to 
achieve targeted drug delivery with minimum side-effects. The physical, chemical and 
pharmacokinetic properties of the active pharmaceutical ingredient can be changed through 
the use of nanotechnology. Combination therapy can be developed with nanotechnology 
systems. Nanotechnology is able to wrap up giant molecules via the covalent cross-linking of 
valuable groups. Certain nanoparticles are below 100 nm size and their original properties are 
not lost. The body does not handle them as foreign molecules and the nanomolecules display 
self-organizing ability to enhance stable and effective use. 
This work describes and discusses the successful preparation and characterization of stable 
nanoparticulate systems based on hyaluronic acid (HA). The effects of the concentration of 
the HA, the cross-linking ratio and the applied medium were investigated. A stable cross-
linked HA-based nanoparticulate semisolid preparation was also investigated in comparison 
with a hydrogel containing linear HA.  
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2 Aims 
 
The aim of my work was to prepare and investigate a cross-linked hialuronic acid 
nanoparticle (CLHA) system produced through the reaction between HA and 
2,2’(ethylenedioxy)bis(ethylamine), using a water-soluble carbodiimide (CDI) as 
condensation agent in aqueous medium.  
 
In the first part of the investigation, the matrix form was synthetized in order to know the 
common effects caused by the different variables. 
The main steps in our experiments were as follows.  
 Parallel reactions under the same conditions and with the same parameters. In this 
case, the variables were the medium, the concentration of HA and the amount of the 
diamine and CDI. The standard parameters were the volume of the medium (50 ml), 
the dissolved HA was adjusted to the same pH, the preparation of the diamine 
solution, the mixing and stirring times, the temperatures applied, and the dialysis and 
freeze-drying methods. 
 Confirmation of the existence of HA nanoparticles by transmission electron 
microscopy (TEM). 
In the second part of the investigation, the manufacturing process was studied, as follows. 
 Comparison of the particle sizes, particle size distributions (PSDs), molecule weight 
distributions and rheological measurements at different phases of the technology. 
 Determination of the effects of the salt concentration on the size of the particles.  
 Determination of the stability of these nanoparticle systems in different media and at 
different feed ratios. 
In the third part of the investigation, HA-based nanoparticulate semisolid preparations were 
compared with a hydrogel containing linear HA. 
 Measurements were made of the rheological properties, and hydration, and irritation 
effects.  
 Skin penetration abilities were determined by using in vitro, ex vivo and in vivo skin 
models.  
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3 Materials and methods 
3.1 Materials 
HA (MW = 4350 kDa) was obtained from Gedeon Richter Ltd. (Budapest, Hungary) in 
sodium salt form. Its quality met the Ph. Eur. 6
th
 requirements. 2,2’-
(Ethylenedioxy)bis(ethylamine) and 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide 
methiodide were purchased from Sigma-Aldrich Ltd. (Budapest, Hungary). The pH was 
adjusted with NaOH and HCl solutions. Millipore water was used throughout the study. 
Transcutol® and Labrasol® were from S&D Chemicals Ltd. (Budapest, Hungary). Glycerol 
85% was from Molar Chemicals Ltd. (Budapest, Hungary).  
3.2 Preparation of cross-linked hialuronic acid nanoparticle (CLHA) 
The cross-linking reaction of HA was carried out in three different media (Table 1). 
Table 1. The notations applied for the media throughout the study 
Medium water NaCl (0.09% w/w) NaCl (0.9% w/w) 
Notation A B C 
 
The matrix end-products of the reactions were synthetized under different reaction conditions 
as concerns the medium applied, the concentration of HA and the cross-linking ratio. The 
nanoparticles obtained were identified by a three-notation system as follows: the initial letter 
refers to the medium and is followed by a number indicating the concentration of HA 
(mg/ml), and the final number indicating stoichiometric cross-linking ratio (feed ratio).  
3.3 Methods 
3.3.1 Dynamic light scattering (DLS) 
The hydrodynamic diameter and size distribution of the CLHA nanosystems were measured 
with a Malvern–Zetasizer NanoZS90 instrument (Malvern Instruments Ltd., Worcestershire, 
UK). The measurements were made by photon correlation spectroscopy at a fixed angle of 
173° at 25 °C. 
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3.3.2 Ultraviolet spectrophotometry 
Transmittances of CLHA nanosystems were analysed with a HP-8453 Ultraviolet 
Spectrophotometer, at 500 nm in optically homogeneous quartz cells at 25 °C. 
3.3.3 Transmission electron microscopy (TEM) 
The size and morphology of the CLHA were determined with a JEOL2000 FX-II 
transmission electron microscope. 
3.3.4 Gel permeation chromatography (GPC) 
GPC is a type of size exclusion chromatography that separates analystes on the basis of size. 
The GPC column applied was the BioSuite 450 HR SEC.  
3.3.5 Rheometry 
Rheological measurements were carried out with a Physica MCR101 rheometer (Anton Paar, 
Austria). A cone-plate measuring device was used in which the cone angle was 1
o
, and the 
thickness of the sample in the middle of the cone was 0.046 mm. 
3.3.6 Hydration and irritation tests 
The Corneometer® CM 825 (Courage and Khazaka Electronic GmbH, Cologne, Germany) is 
the instrument commonly used worldwide to determine the level of hydration of the skin 
surface. The Tewameter® TM 300 (Courage and Khazaka Electronic GmbH, Cologne, 
Germany) is the most generally accepted measuring device for the assessment of 
transepidermal water loss (TEWL).  
3.3.7 In vitro API release and skin penetration measurements 
Membrane diffusion and permeability studies were performed with a vertical Franz diffusion 
cell system (Hanson Microette TM Topical & Transdermal Diffusion Cell System, Hanson 
Research Corporation, Chatsworth, CA, USA). 
3.3.8 Preparation of human epidermis 
Excised human skin from patients who had undergone abdominal plastic surgery was used for 
the skin permeation studies. The epidermis was separated from the underlying dermis using 
the heat-separation technique. After excision, the subcutaneous fatty tissue was removed and 
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individual portions were immersed in water bath at 60 °C for 90 s and the epidermis was 
gently removed from the underlying dermis using forceps. 
3.3.9 In vivo animal study 
The modified skinfold chamber model was used. The experiments were performed on 15-
week-old male hairless mice of strain SKH. The full skin was removed from one side of the 
skinfold. On the other side of the skinfold, the skin comprised complete epidermis, dermis 
and skin muscle. HA was determined by GPC. 
 
4 Results 
4.1 Results on the nanoparticle products 
4.1.1  DLS results 
The cross-linking process of HA can result in intramolecular and intermolecular cross-linking. 
A proportion of the CLHA nanoparticles were formed as small, individual particles; however, 
large particles were also produced. The large particles can be aggregates, associations caused 
by secondary interactions or intermolecular cross-linked particles. The hydrodynamic 
diameter of the nanoparticles from the reaction mixtures was therefore not monomodal, so the 
Z-average size was used to compare hydrodynamic size. 
The end-point of Number Distribution Profile (NDP) for the reaction mixture of the matrix 
products shifts to smaller particles with increase of the concentration of HA at the same feed 
ratio (25%). The variation in size of the CLHA finds, with a higher concentration of native 
HA forming smaller nanoparticles. The explanation is that a higher concentration of HA leads 
to an increasing possibility of intermolecular cross-linking, thereby leading to more and more 
compact CLHA. This tendency indicates that the intermolecular forces between the 
nanoparticles are very low. Further, TEM showed that the HA nanoparticles were well 
dispersed with a spherical shape.  
Figures 1a-c indicated that applied smaller feed ratio (12% or 7%) is sufficient to create an 
appropriate amount of intermolecular binding when an adequate concentration of HA is used. 
This is probably caused by the decrease in the feed ratio from 25% to 7%, and the setting of 
the pH for reaction mixtures does not significantly influence the cross-linked systems. 
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The overall charge of the CLHA is negative. The overall charge of the CLHA nanoparticles 
could be modified by adjusting the pH, but mutual repulsive forces and electric double layer 
were decreased by higher salinity. 
 
 
a 
   
b c 
Figure 1. Effects of a smaller feed ratio of HA, pH and purification on the PSD of CLHA 
under the indicated reaction conditions: a: cHA = 3 mg/ml, cross-linking ratio: 25%, prepared 
in water; b: cHA = 3 mg/ml, cross-linking ratio: 12%, prepared in water; c: cHA = 3 mg/ml, 
cross-linking ratio: 7%, prepared in water 
 
Nevertheless, no significant correlations were established between the hydrodynamic 
diameters of swelled particles and the physico-chemical parameters of the reactions; the size 
and size distribution by number of all CLHA particles were below 20 nm. 
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However, we observed differences between the PSDs of the reaction mixture and the dialysed 
samples. The latter-mentioned profiles are indicated ‘after dial’ in Figure 1. Since the PSDs of 
all of the tested dialysed matrix products were similar and shifted towards larger particle 
sizes, it was clear that the smaller particles were lost when the reaction mixtures were 
dialyzed. 
 
4.1.2 Hydrodynamic diameter (HD) 
The reaction mixtures are not monomodal, so the Z-average size can only be used to compare 
results with samples measured via matrix products by the same technique. The HD was 
measured with DLS. The size of a particle was calculated from the translational diffusion 
coefficient by using the Stokes-Einstein equation:  
HD =kT/3πµD (1) 
 where: HD = hydrodynamic diameter, D = translational diffusion coefficient, k = 
Boltzmann’s constant, T = absolute temperature, and µ = viscosity. 
The translational diffusion coefficient D depends not only on the size of the particle “core”, 
but also the surface structure, and on the concentration and type of ions in the medium. A 
comparison of the A_1_25, A_2_25 and A_3_25 matrix products with the other matrix 
products reveals that the low conductivity medium water produces an extended double layer 
of ions around the particle, reducing the diffusion speed and resulting in a larger, apparent HD 
than in other media. 
4.1.3 TEM results 
 
TEM confirmed the existence of small nanoparticles (~10 nm) not only in the A_1_25 
reaction mixture, but also in the A_3_7 mixture, where the HA concentration was higher and 
the feed ratio was lower. Increasing concentration of the native HA reduced the size of the 
dried particles to below 110 nm. 
4.1.4 GPC results 
GPC trace of HA shows with the broad size distribution of a linear biopolymer. We have 
compared GPC chromatograms of hyaluronan nanoparticles before and after dialysis. Before 
9 
 
dialysis the unimodal nanoparticulate system displayed a broad size distribution. The 
retention time for the nanoparticles increased; smaller particles were formed during the cross-
linking reaction.  
Following dialysis with cellulose dialysis tubes (molecular weight cut-off = 12,000 Da), the 
intensity of the GPC chromatogram of the purified reaction mixture was reduced at higher 
retention times. This suggests that smaller particles were formed during the cross-linking 
reaction, diffused through the membrane tube and were lost during the dialysis.  
 
4.1.5 Transmittance results 
The transmittance values were measured for the reaction mixtures of the different CLHA 
matrix products. These colloid dispersions are transparent or mildly opalescent systems. The 
transmittance values ranged between 91% and 99%. The results correspond with the Bouguer-
Lambert-Beer law that transmittance values can be reduced due to increased concentration. 
Stable colloid particles were formed over a wide pH range of pH 3–8 in the different media 
during 3 weeks. The stability of these nanoparticles was not dependent on the medium or the 
feed ratio (from 7 to 25): no aggregation was found after three weeks.  
4.1.6 Rheology 
Viscosity, an important property of colloid systems, is related to the nature and the extent of 
the intermolecular interactions, and the entanglements of the polymer chains. The flow curves 
of the purified nanoparticle system run lower than that for the native HA, which proves that 
the successful cross-linking method resulted in small particles. 
The comparison of the curve for the purified nanoparticle system and that for the unpurified 
nanoparticle system reveals that the curve for the reaction mixture runs lower than that for the 
dialysed sample, and the unpurified nanoparticle system contains small particles, which are 
missing from the purified sample. 
The small particles produced in the applied cross-linking process can be lost during the 
purification, while the larger nanoparticles can remain in the purified system. The properties 
of these purified systems were determined by the larger particles. 
4.2 Results on the semisolid linear HA and CLHA preparations 
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4.2.1  Results of rheological measurements 
 
Rheological characteristics (viscosity and flow curve) are important properties of colloid 
systems. The gels applied to the skin had appropriate rheological properties. The shear stress 
of the cross-linked HA (CLHA) was lower than that of the linear HA, which confirmed the 
successful cross-linking and the formation of smaller particles (Figure 2). 
 
Figure 2. Flow curves of semisolid preparations containing linear HA or cross-linked HA 
4.2.2 Results of hydration and irritation tests 
 
Corneometry determines the water content of the skin surface, mainly the stratum corneum. It 
was found that there were no differences in the hydration effects of the CLHA and linear HA. 
Linear HA is known to hydrate the skin surface; after the chemical modification, the cross-
linked HA retained the hydration effect (Figure 3). TEWL proved to be decreased after the 
application of the CLHA gel, which means that it undergoes longer hydration with no 
irritation effect on the skin (Figure 4). 
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Figure. 3. Hydration effects of linear HA and cross-linked HA
 
 
 
Figure. 4.Transepidermal water loss of linear and cross-linked HA 
4.2.3 Diffusion, penetration and in vivo studies 
Figure 5 depicts the cumulative amount per unit area of linear HA and CLHA that diffused 
through the synthetic.  
It is clear that the diffusion of the CLHA was more intensive. After 10 h, a steady state was 
seen. The calculated result after 24 h: 1028 μg/cm2. The linear HA also diffused through the 
synthetic membrane, but more slowly, and the amount diffused was significantly less, at 739 
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μg/cm2 (after 24 h) The better diffusion of the cross-linked HA may be explained by the lower 
viscosity and the smaller particle size. The penetration through the human epidermis is 
illustrated in Figure 6. 
 
Figure 5. Cumulative amount of HA that diffused through a synthetic membrane 
 
Figure 6. Cumulative amount of HA that penetrated through the human epidermis 
There was no detectable penetration of linear HA during the observation period, whereas the 
level of penetration of CLHA was 200 μg/cm2.  
Figure 7 demonstrates the penetration of the CLHA and the linear HA as a function of time 
through living animal skin. 
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Figure 7. Demonstrates the penetration of the cross-linked and linear HA as a function of 
time through living animal skin. 
 
Similarly as in the in vitro human epidermis study, there was no detectable penetration of 
linear HA. The quantity of CLHA that penetrated displayed a considerable elevation during 
the observation period; it increased steadily to about 26 μg/cm2 by the end of the experiment. 
5 Summary 
 
The primary aim of my Ph.D. work was to prepare and investigate a crosslinked HA.  
 The nanoparticles obtained were spherical with a size in the nanometric scale. Their 
physico-chemical properties, including the transmittance of an aqueous system 
containing nanoparticles and the hydrodynamic size of the HA nanoparticles, were 
controlled by varying the cross-linking density, the concentration of native HA and 
the parameters of the media. 
 The TEM and rheology results proved the existence of systems of  well-dispersed 
spherical HA nanoparticles. 
The manufacturing process was studied. 
 The DLS, transmittance and TEM results demonstrated that increase of the 
concentration of the native HA (from 1 mg/ml to 3 mg/ml) resulted in smaller product 
particles.  
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Comparisons of the particle sizes (TEM), particle size distributions (DLS) and 
molecular weight distributions in different phases of the technology led to the 
recognition of the loss of the smaller particles during the dialysis. The rheology results 
support the DLS and GPC results: the majority of the cross-linked nanoparticles are 
formed with a size less than 20 nm, but these particles can be lost during the 
purification. 
 The electrical double layer and the measured HD were suppressed in media of higher 
conductivity. When the pH was increased, the HD displayed an increasing tendency. 
Narrower particle size range systems were observed at higher salinity, which did not 
change significantly when the pH was modified. 
 The stability of these nanoparticles was not dependent on the medium and feed ratio 
(from 7 to 25%), and no aggregation was found after 3 weeks. 
A semisolid HA-based nanoparticulate preparation was investigated in comparison with a 
hydrogel containing linear HA. 
 This experimental work has revealed the advantages of CLHA over linear HA in 
dermal applications. The cross-linking of the linear HA molecule changes its 
rheological parameters. The shear stress decreases in response to cross-linking. The 
dynamic rheological measurements proved that the specific elastoviscous property of 
the HA gel was slightly changed after the cross-linking procedure. 
  The corneometric tests revealed that the hydration effect was preserved. There was no 
irritant effect of the CLHA molecule in TEWL tests. 
  The diffusion and penetration study demonstrated that the cross-linking of HA 
resulted in better diffusion through a synthetic membrane and better penetration 
through the human epidermis and living animal skin than when linear HA was used, 
where no penetration was observed. The cross-linking of HA makes it suitable for 
transdermal applications, promoting hydration in deeper layers of the skin and giving 
the possibility of a signal effect for HA production. CLHA can lead to the 
development of an API carrier system for deep penetration into the skin. 
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